Colin T. Dourish

Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety

Jon K. Shepherd, Savraj Grewal, Allan Fletcher et al. · Psychopharmacology · 1994 · 733 citations

Experimental Psychopathology, Behavioral Sciences, Psychiatry +14

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

Allan Fletcher, Elaine A. Forster, David J. Bill et al. · Behavioural Brain Research · 1995 · 521 citations

Neurophysiology, Behavioral Neuroscience, Medicine +14

Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat

Colin T. Dourish, Peter H. Hutson, G. Curzon · Psychopharmacology · 1985 · 318 citations

Psychoactive Drug, Putative Serotonin Agonist, Medicine +11

Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

Steven P. Vickers, Peter G. Clifton, Colin T. Dourish et al. · Psychopharmacology · 1999 · 288 citations

Medicine, Serotonin 5-Ht 2C, Neuropeptide Receptor +5

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

Colin T. Dourish, Michael F. O‘Neill, J. Coughlan et al. · European Journal of Pharmacology · 1990 · 269 citations

Molecular Pharmacology, Health Sciences, Pain Medicine +10